1. Home
  2. Companies
  3. United States
  4. Professional Services
  5. Biotechnology Research
  6. Alnylam Pharmaceuticals
A

Alnylam PharmaceuticalsBiotechnology Research · 1001-5000 · B2B contacts & data

5,000 Employees
2002 Founded
$5.1B Total Funding
Biotechnology Research Industry
Biotechnology Research United States B2B Est. 2002

Company Overview

Sector Professional Services
Headcount 5,000 employees (1001-5000)
Company type Public company
Revenue $4.3B
Headquarters United States
Website alnylam.com
Last updated 18 Aug 2026

Departments actively hiring 11 departments

Engineering and technical
Finance & accounting
General management
Legal
Marketing
Medical
Operations
Other
Project management
Research
Sales

These departments at Alnylam Pharmaceuticals are actively recruiting: a strong signal to time your outreach.

Funding

Last round Other · $661M
Total funding $5.1B (13 rounds)
Corporate Round N/A Jan 2002
Series B $16M Aug 2002
Private Equity Round $25M Jul 2003
Post-IPO Equity $30M Jun 2004
Post-IPO Equity $10M Mar 2011
Post-IPO Equity $700M Jan 2014
Post-IPO Equity $450M Jan 2015
Post-IPO Equity $800M Apr 2019
Post-IPO Debt $750M Apr 2020
Post-IPO Equity $250M Apr 2020
Post-IPO Debt $900M Sep 2022
Post-IPO Debt $500M Sep 2025
Post-IPO Debt $661M Oct 2025

Companies similar to Alnylam Pharmaceuticals

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals is a company active in the Biotechnology Research space, based in United States. The company was founded in 2002 and has a workforce of roughly 5,000 people. Alnylam Pharmaceuticals belongs to the Professional Services sector, with a specific positioning on Biotechnology Research. Alnylam Pharmaceuticals is a B2B company, primarily serving business clients and professional organisations. Alnylam Pharmaceuticals has raised funding across 13 rounds totalling $5.1B. Annual revenue is estimated at around $4.3B. Sales teams can rely on this profile to qualify Alnylam Pharmaceuticals, spot business signals, and connect with verified decision makers.

Activity & Market

Alnylam Pharmaceuticals is positioned on the Biotechnology Research segment, within the Professional Services sector. As a B2B company, Alnylam Pharmaceuticals primarily serves business clients and professional organisations. The company is categorised as “Public company”.

Decision Makers at Alnylam Pharmaceuticals

23C-Level 57VP 650Heads
Decision maker Email Phone

Zeliq has found 730 decision makers at Alnylam Pharmaceuticals. Create a free Zeliq account to access their verified emails and direct phone numbers.

See 730 decision makers on Zeliq →

New decision makers last 6 months

2C-Level 3VP 98Heads

103 new decision makers joined Alnylam Pharmaceuticals in the last 6 months, a strong signal to time your outreach.

Contact the new decision makers on Zeliq →

Team Structure headcount by department

Research
432
Medical
348
Sales
248
Other
232
Operations
222
General Management
183
Technical
120
Project Management
112

How to prospect Alnylam Pharmaceuticals's departments

Research

The company's largest department (432 people), currently in an active hiring phase. Data quality and reproducibility are core concerns: a strong angle if your offer touches either.

Medical

A team of 348 people, currently hiring. Time with patients is the priority: position your solution as a way to give hours back to care.

Sales

This 248-person department is actively recruiting. These profiles handle outreach daily and respond well to concrete pitches about pipeline, productivity and prospecting tooling.

Other

Hiring is underway in this team of 232 people. Mixed profiles gather here: a discovery-first approach works better than a packaged pitch.

Operations

A team of 222 people, currently hiring. Operations leaders live in the concrete: a pilot scoped on one process will convince more than a demo.

General Management

This 183-person department is actively recruiting. Executive attention is scarce: one sharp sentence on business impact beats three paragraphs of features.

FAQ Alnylam Pharmaceuticals

What industry does Alnylam Pharmaceuticals operate in?

Alnylam Pharmaceuticals is active in the Biotechnology Research industry, specifically in the Professional Services category.

How many employees does Alnylam Pharmaceuticals have?

Alnylam Pharmaceuticals has approximately 5,000 employees (in the 1001-5000 range). This figure is an estimate to help qualify the account, not a legally certified number.

How do I find contacts at Alnylam Pharmaceuticals?

Zeliq helps you surface decision makers at Alnylam Pharmaceuticals, enrich them with verified emails and direct dials, and reach out through personalised multichannel prospecting sequences.

Where is Alnylam Pharmaceuticals headquartered?

Alnylam Pharmaceuticals is headquartered in United States.

Which departments are hiring at Alnylam Pharmaceuticals?

Hiring is currently active at Alnylam Pharmaceuticals in these departments: Engineering and technical, Finance & accounting, General management. A useful signal to prioritise and time your prospecting.

Why use this data before prospecting Alnylam Pharmaceuticals?

With Alnylam Pharmaceuticals's firmographics and business signals at hand, you can prioritise the account, personalise your approach, and contact the right people straight away.